Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Allan F. Pyesmany"'
Autor:
Neil J. Grossman, W A Bleyer, Gregory H. Reaman, A R Ablin, Louis Novak, Allan F. Pyesmany, Paul S. Gaynon, J Z Finklestein, V C Albo, Peter G. Steinherz
Publikováno v:
Journal of Clinical Oncology. 11:2234-2242
PURPOSE On past Childrens Cancer Group (CCG) trials, children with acute lymphoblastic leukemia and unfavorable presenting features had obtained an event-free survival (EFS) rate of no better than 50%. Following promising pilot experience, this study
Autor:
G. Denman Hammond, Linda P. Miller, Allan F. Pyesmany, Paul Rogers, Stuart E. Siegel, Robert J. Wells, Lawrence J. Wolff, Jonathan D. Buckley
Publikováno v:
Cancer. 67:2235-2240
Amsacrine (AMSA) and cyclocytidine were studied as retrieval therapy in 122 pediatric patients with acute nonlymphoblastic leukemia (ANLL). Patients either failed to achieve sustained initial remissions or were in relapse. Induction therapy consisted
Autor:
Torrey L. Mitchell, Janet Franklin, Peter G. Steinherz, Nyla A. Heerema, Leonard A. Mattano, Caroline Hastings, Mei K. La, Cheryl Edens, Kathy Bertolone, Cynthia DeLaat, Lawrence J. Ettinger, Nita L. Seibel, Harland Sather, James B. Nachman, Charles M. Rubin, Paul S. Gaynon, Allan F. Pyesmany, David R. Freyer
Publikováno v:
Blood. 111(5)
Longer and more intensive postinduction intensification (PII) improved the outcome of children and adolescents with “higher risk” acute lymphoblastic leukemia (ALL) and a slow marrow response to induction therapy. In the Children's Cancer Group s
Autor:
Peter G. Steinherz, Charles M. Rubin, Allan F. Pyesmany, David Robert Freyer, Caroline Hastings, Cheryl Edens, Harland Sather, Janet Franklin, Leonard A. Mattano, James B. Nachman, Nita L. Seibel, Paul S. Gaynon, Torrey L. Mitchell, Lawrence J. Ettinger, Cynthia DeLaat, Kathy Bertolone, Nyla A. Heerema
Publikováno v:
Blood. 108:1870-1870
In prior studies, children and adolescents with markedly elevated (ME) WBC≥200,000 had a poor outcome. We examined the outcome of these patients enrolled on CCG l961 (n=250) and compared them to other patients with WBC
Autor:
Ronald L. Chard, Gussie R. Higgins, Allan F. Pyesmany, Nasser Movassaghi, Denman Hammond, Harland N. Sather, Robert L. Baehner
Publikováno v:
Medical and Pediatric Oncology. 12:352-356
A study of children in relapse with acute nonlymphocytic leukemia (ANLL) previously maintained in remission with combination chemotherapy including cytosine arabinoside (Ara-C) was undertaken by Children's Cancer Study Group (CCSG) to assess the effi